|
Jul 23
|
Are Investors Undervaluing Catalent, Inc. (NYSE:CTLT) By 24%?
|
|
Jun 7
|
Why Is Catalent (CTLT) Up 0.4% Since Last Earnings Report?
|
|
May 13
|
Catalent's (CTLT) Latest Partnership to Boost Clinical Trials
|
|
May 9
|
Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
|
|
May 9
|
Decoding Catalent Inc (CTLT): A Strategic SWOT Insight
|
|
May 8
|
Catalent (CTLT) Reports Q3 Loss, Misses Revenue Estimates
|
|
May 8
|
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results
|
|
May 3
|
FTC Seeks More Information on $16.5 Billion Novo-Catalent Deal
|
|
May 3
|
US FTC seeks more information on Novo Nordisk parent-Catalent deal
|
|
May 3
|
UPDATE 2-US FTC seeks more information on Novo Nordisk parent-Catalent deal
|
|
May 3
|
How Novo-Catalent Deal Affects Halozyme (HALO)?
|
|
May 3
|
Here’s How Novo Holdings’ Catalent (CTLT) Acquisition Affects Laughing Water Capital
|
|
May 2
|
Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
|
|
Apr 25
|
TAK or CTLT: Which Is the Better Value Stock Right Now?
|
|
Apr 11
|
Charles River (CRL) Forges Collaboration With Ship of Theseus
|
|
Apr 8
|
Novo Nordisk parent refiles US application on Catalent deal
|
|
Apr 8
|
UPDATE 1-Novo Nordisk parent refiles US application on Catalent deal
|
|
Apr 6
|
Ares, Blue Owl Lead $4.8 Billion Private Debt for Catalent Deal
|
|
Mar 28
|
13 Hot Stocks to Invest in According to Wall Street Analysts
|
|
Mar 9
|
The Top 3 Pharma Stocks to Buy in March 2024
|